Data availability
No datasets were generated or analysed during the current study.
References
Barkan T (2019) Graphene: the hype versus commercial reality. Nat Nanotechnol 14(10):904–906
Loret T et al (2022) Innate but not adaptive immunity regulates lung recovery from chronic exposure to graphene oxide nanosheets. Adv Sci 9(11):2104559
Andrews JP et al (2024) First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses. Nat Nanotechnol. https://doi.org/10.1038/s41565-023-01572-3
Commission E et al (2020) The NanoDefine methods manual–2020. 2020: Publications Office of the European Union
Graphene Classification Framework. The Graphene Council 2021. https://www.thegraphenecouncil.org/page/GCF
Lovén K et al (2021) Emissions and exposures of graphene nanomaterials, titanium dioxide nanofibers and nanoparticles during down-stream industrial handling. J Eposure Sci Environ Epidemiol 31(4):736–752
Susanne Resch AF, Dumitru Ulieru Juan Antonio Tamayo Ramos, Sonia Martel Martin (2019) Manual of good practice, protocols and steps in the safe by design approach of production of carbon-based NMs
Author information
Authors and Affiliations
Contributions
Not applicable for News and Views.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ratwani, C.R., Barkan, T. Human trials suggest graphene inhalation may be safe. Graphene and 2D mater (2024). https://doi.org/10.1007/s41127-024-00077-7
Published:
DOI: https://doi.org/10.1007/s41127-024-00077-7